(Q46535413)

English

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands

scientific article published on 17 June 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

0 references

author name string

Julia M Hofstra

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

Jack F M Wetzels

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

language of work or name

0 references

publication date

17 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

23

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

3534-3538

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN350

21 January 2018

Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN350

21 January 2018

Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN350

21 January 2018

Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN350

21 January 2018

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN350

21 January 2018

A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN350

21 January 2018

Identifiers

10.1093/NDT/GFN350

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559961

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46535413&oldid=2116904791"